# A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

> **NCT04740164** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 66 (actual)

## Conditions studied

- Bile Duct Carcinoma
- Gallbladder Carcinoma
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **PROCEDURE:** Endoscopic Retrograde Cholangiopancreatography
- **PROCEDURE:** Endoscopic Retrograde Cholangiopancreatography

## Key facts

- **NCT ID:** NCT04740164
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2023-05-04
- **Final completion:** 2023-05-04
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04740164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04740164, "A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04740164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*